Vivus

Investor's Business Daily

Vivus (VVUS) shares rose 13.3% to 11.73 Wed. after insurer Aetna (AET) on Tue. revised its weight-loss-treatment policy to include Vivus' obesity drug Qsymia.

Rates

View Comments (0)